SCHEMBL8974501

SCHEMBL8974501

CS(=O)(=O)c1ccc(C2=CC(C(F)(F)F)(C(F)(F)F)C=C2c2ccc(F)nc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 15/20 0.47
PTGS1 P23219 4/20 0.47
KCNH2 Q12809 2/20 0.41
MAP4K4 O95819 1/20 0.41
PIK3CA P42336 1/20 0.41
MINK1 Q8N4C8 1/20 0.41
PI4KB Q9UBF8 1/20 0.41
KIF11 P52732 1/20 0.39
MMP2 P08253 1/20 0.39
MMP9 P14780 1/20 0.39
MMP13 P45452 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8974291 0.88 KCNH2 (0.53) PTGS2PTGS1KCNH2MAP4K4PIK3CA
SCHEMBL8974555 0.87 KIF11 (0.41) PTGS2PTGS1KIF11MMP2MMP9
SCHEMBL8974088 0.85 PTGS2 (0.50) PTGS2PTGS1KCNH2MAP4K4PIK3CA
SCHEMBL8974180 0.85 PTGS2 (0.50) PTGS2PTGS1MMP2MMP9MMP13
SCHEMBL8973922 0.83 PTGS2 (0.66) PTGS2PTGS1
SCHEMBL9118925 0.83 PTGS2 (0.70) PTGS2PTGS1MMP2MMP9MMP13
SCHEMBL8974363 0.82 PTGS2 (0.47) PTGS2PTGS1KCNH2MAP4K4PIK3CA
SCHEMBL8973837 0.82 PTGS2 (0.47) PTGS2PTGS1KCNH2MAP4K4PIK3CA
SCHEMBL8973786 0.81 PTGS2 (0.50) PTGS2PTGS1
SCHEMBL8974171 0.81 PTGS2 (0.48) PTGS2PTGS1KIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1995030656-A1 SUBSTITUTED CYCLOPENTADIENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1995-11-16 WO claimed
US-5576339-A Pyridyl substituted cyclopentadienes for the treatment of inflamation HUANG HORNG-CHIH (US) 1996-11-19 US disclosed
WO-1995030656-A1 SUBSTITUTED CYCLOPENTADIENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1995-11-16 WO disclosed
US-5418254-A Side effect reduction G. D. SEARLE & CO. (US) 1995-05-23 US disclosed